RAGE inhibition reduces acute lung injury in mice

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Blondonnet, Raiko ^a,b   Audard, Jules ^a,b   Belville, Corinne ^b   Clairefond, Gael ^b   Lutz, Jean ^a,b   Bouvier, Damien ^a,b   Roszyk, Laurence ^a,b   Gross, Christelle ^b   Lavergne, Marilyne ^b   Fournet, Marianne ^b   Blanchon, Loic ^b   Vachias, Caroline ^b   Damon Soubeyrand, Christelle ^b   Sapin, Vincent ^a,b   Constantin, Jean Michel ^a,b   Jabaudon, Matthieu ^a,b  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ANTIINFLAMMATORY AGENT; AUTACOID; BIOLOGICAL MARKER; CYTOKINE; ION CHANNEL; MONOCLONAL ANTIBODY;

ACUTE LUNG INJURY; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOPSY; BLOOD GAS ANALYSIS; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS EPITHELIUM CELL; LUNG GAS EXCHANGE; MALE; METABOLISM; MOUSE; SEVERITY OF ILLNESS INDEX;

ACUTE LUNG INJURY; ALVEOLAR EPITHELIAL CELLS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BIOMARKERS; BIOPSY; BLOOD GAS ANALYSIS; BLOOD-AIR BARRIER; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; ION CHANNELS; MALE; MICE; RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS; SEVERITY OF ILLNESS INDEX;

EID: 85026871410     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-07638-2     Document Type: Article

References (46)

1. ARDS Definition, Task Force et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 307, 2526-2533 (2012).
2. Bellani, G. et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA 315, 788-800 (2016).
3. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N. Engl. J. Med. 342, 1301-1308 (2000).
4. Papazian, L. et al. Neuromuscular blockers in early acute respiratory distress syndrome. N. Engl. J. Med. 363, 1107-1116 (2010).
5. Guérin, C. et al. Prone positioning in severe acute respiratory distress syndrome. N. Engl. J. Med. 368, 2159-2168 (2013).
6. Uchida, T. et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am. J. Respir. Crit. Care Med. 173, 1008-1015 (2006).
7. Hofmann, M. A. et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97, 889-901 (1999).
8. Abraham, E., Arcaroli, J., Carmody, A., Wang, H. & Tracey, K. J. HMG-1 as a mediator of acute lung inflammation. J. Immunol. 165, 2950-2954 (2000).
9. Xie, J., Méndez, J. D., Méndez-Valenzuela, V. & Aguilar-Hernández, M. M. Cellular signalling of the receptor for advanced glycation end products (RAGE). Cell. Signal. 25, 2185-2197 (2013).
10. Hanford, L. E. et al. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J. Biol. Chem. 279, 50019-50024 (2004).
11. Calfee, C. S. et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 63, 1083-1089 (2008).
12. Jabaudon, M. et al. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Crit. Care Med. 39, 480-488 (2011).
13. Jabaudon, M. et al. Soluble Receptor for Advanced Glycation End-Products Predicts Impaired Alveolar Fluid Clearance in Acute Respiratory Distress Syndrome. Am. J. Respir. Crit. Care Med. 192, 191-199 (2015).
14. Ware, L. B. & Matthay, M. A. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 163, 1376-1383 (2001).
15. Matthay, M. A. Resolution of pulmonary edema. Thirty years of progress. Am. J. Respir. Crit. Care Med. 189, 1301-1308 (2014).
16. Matthay, M. A., Folkesson, H. G. & Clerici, C. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol. Rev. 82, 569-600 (2002).
17. Dobbs, L. G. et al. Highly water-permeable type I alveolar epithelial cells confer high water permeability between the airspace and vasculature in rat lung. Proc. Natl. Acad. Sci. USA 95, 2991-2996 (1998).
18. Downs, C. A., Kreiner, L. H., Johnson, N. M., Brown, L. A. & Helms, M. N. Receptor for Advanced Glycation End-Products Regulates Lung Fluid Balance via Protein Kinase C-gp91(phox) Signaling to Epithelial Sodium Channels. Am. J. Respir. Cell Mol. Biol. 52, 75-87 (2015).
19. Goova, M. T. et al. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am. J. Pathol. 159, 513-525 (2001).
20. Sternberg, D. I. et al. Blockade of receptor for advanced glycation end product attenuates pulmonary reperfusion injury in mice. J. Thorac. Cardiovasc. Surg. 136, 1576-1585 (2008).
21. Zhang, H. et al. Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury. Am. J. Respir. Crit. Care Med. 178, 356-362 (2008).
22. Ogawa, E. N. et al. Contribution of high-mobility group box-1 to the development of ventilator-induced lung injury. Am. J. Respir. Crit. Care Med. 174, 400-407 (2006).
23. Kuipers, M. T. et al. The receptor for advanced glycation end products in ventilator-induced lung injury. Intensive Care Med Exp 2, 22 (2014).
24. Liliensiek, B. et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J. Clin. Invest. 113, 1641-1650 (2004).
25. Lutterloh, E. C. et al. Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection. Crit. Care 11, R122 (2007).
26. Patel, B. V., Wilson, M. R. & Takata, M. Resolution of acute lung injury and inflammation: a translational mouse model. Eur. Respir. J. 39, 1162-1170 (2012).
27. Jabaudon, M. et al. Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study. PLoS One 10, e0135857 (2015).
28. Creagh-Brown, B. C., Quinlan, G. J., Evans, T. W. & Burke-Gaffney, A. The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target? Intensive Care Med. 36, 1644-1656 (2010).
29. Christaki, E. et al. A monoclonal antibody against RAGE alters gene expression and is protective in experimental models of sepsis and pneumococcal pneumonia. Shock 35, 492-498 (2011).
30. Schmidt, A. M., Yan, S. D., Yan, S. F. & Stern, D. M. The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta 1498, 99-111 (2000).
31. Park, L. et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat. Med. 4, 1025-1031 (1998).
32. Renard, C. et al. Recombinant advanced glycation end product receptor pharmacokinetics in normal and diabetic rats. Mol. Pharmacol. 52, 54-62 (1997).
33. Bierhaus, A. et al. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 83, 876-886 (2005).
34. Folkesson, H. G., Matthay, M. A., Hébert, C. A. & Broaddus, V. C. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J. Clin. Invest. 96, 107-116 (1995).
35. Zhang, Y.-W. et al. Reduced lung water transport rate associated with downregulation of aquaporin-1 and aquaporin-5 in aged mice. Clin. Exp. Pharmacol. Physiol. 36, 734-738 (2009).
36. Sun, C.-Z. et al. Effect of dobutamine on lung aquaporin 5 in endotoxine shock-induced acute lung injury rabbit. J. Thorac. Dis. 7, 1467-1477 (2015).
37. Ma, T., Fukuda, N., Song, Y., Matthay, M. A. & Verkman, A. S. Lung fluid transport in aquaporin-5 knockout mice. J. Clin. Invest. 105, 93-100 (2000).
38. Zhang, Z.-Q., Song, Y.-L., Chen, Z.-H., Shen, Y. & Bai, C.-X. Deletion of aquaporin 5 aggravates acute lung injury induced by Pseudomonas aeruginosa. J. Trauma 71, 1305-1311 (2011).
39. Sheng, S.-J. et al. Biphasic modulation of ?-ENaC expression by lipopolysaccharide in vitro and in vivo. Mol. Med. Rep. 10, 773-777 (2014).
40. Vazzana, N., Santilli, F., Cuccurullo, C. & Daví, G. Soluble forms of RAGE in internal medicine. Intern. Emerg. Med. 4, 389-401 (2009).
41. Rittirsch, D., Hoesel, L. M. & Ward, P. A. The disconnect between animal models of sepsis and human sepsis. J. Leukoc. Biol. 81, 137-143 (2007).
42. Galasko, D. et al. Clinical trial of an inhibitor of RAGE-A? interactions in Alzheimer disease. Neurology. doi:10. 1212/ WNL. 0000000000000364 (2014).
43. van Zoelen, M. A. D. et al. Ligands of the receptor for advanced glycation end products, including high-mobility group box 1, limit bacterial dissemination during Escherichia coli peritonitis. Crit. Care Med. 38, 1414-1422 (2010).
44. van Zoelen, M. A. D. et al. Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice. J. Infect. Dis. 200, 765-773 (2009).
45. Wittkowski, H. et al. Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome. Crit. Care Med. 35, 1369-1375 (2007).
46. Matute-Bello, G. et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am. J. Respir. Cell Mol. Biol. 44, 725-738 (2011).